Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004 - Requirement for therapeutic drug monitoring

Therapeutic Drug Monitoring

Volumn 28, Issue 3, 2006, Pages 367-374

  Holland, Diane T ^a   DiFrancesco, Robin ^b   Connor, James D ^a   Morse, Gene D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antiretrovirals (ARV); Proficiency testing; Therapeutic drug monitoring

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; DATA ANALYSIS; DRUG DETERMINATION; DRUG MONITORING; GOOD LABORATORY PRACTICE; HEALTH CARE QUALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUALITY CONTROL;

ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASS SPECTROMETRY; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33748177814     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000211817.58052.b8     Document Type: Article

References (13)

1. Holland DT, DiFrancesco RStone J, et al. Quality assurance program for clinical measurement of antiretrovirals: AACTG proficiency testing program for pharmacology laboratories. Antimicrob Agent Chemother. 2004;48:824-831.
2. US Department of Health and Human Services. Medicare, medicaid and CLIA programs; regulations implementing the Clinical Laboratory improvement amendments of 1988, (CLIA): final rule. Fed Regist. 1992:57:7002-7186.
3. Hugen PWH, Verweij-van Wissen CP, Burger DM, et al. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1999;727:139-149.
4. Droste JA, Verweij-Van Wissen CP, Burger DM. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography. Ther Drug Monit. 2003;25:393-399.
5. Poirier JM, Robidou P, Jaillon P. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography. Ther Drug Monit. 2005;27:186-192.
6. Aarnoutse RE, Verweij-van Wissen CP, Underberg WJM, et al. High-performance liquid chromatography of HIV protease inhibitors in human biological matrices. J Chrom B. 2001;764:363-384.
7. Acosta EP, Gerber JG. Position paper on therapeutic drug monitoring of antiretroviral agents. AIDS Res Hum Retroviruses. 2002;18:825-834.
8. Aarnoutse RE, Schapiro JM, Boucher CA, et al. Therapeutic drug monitoring: an aid to optimizing response to antiretroviral drugs? Drugs. 2003;63:741-753.
9. Jenny RW, Jackson KY. Evaluation of the rigor and appropriateness of CLIA '88 toxicology proficiency testing standards. Clin Chem. 1992;38:496-500.
10. Droste JAH, Aarnoutse RE, Koopmans PP, et al. Evaluation of antiretroviral drug measurements by an interlaboratory quality control program. J Acquir Immune Defic Syndr. 2003;32:287-291.
11. Aarnoutse RE, Verweij-van Wissen CP, van Ewijk-Beneken Kolmer EW, et al. International interlaboratory quality control program for measurement of antiretroviral drugs in plasma. Antimicrob Agents Chemother. 2002;46:884-886.
12. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019-3030.
13. Thompson M, Lowthian PJ. The frequency of rounds in a proficiency test: does it affect the performance of participants? Analyst. 1998;123:2809-2812.